Drug comparisons
Rosiglitazone vs Insulin Icodec
Compare Rosiglitazone and Insulin Icodec for type 2 diabetes. Oral insulin sensitizer vs once-weekly basal insulin: efficacy, safety, dosing differences.
No comparison dimensions are available for this page.
Clinical context
This comparison occurs when type 2 diabetes patients consider switching from oral sensitizers to weekly insulin therapy.
Bottom line
Rosiglitazone suits early insulin-resistant type 2 diabetes as a daily pill while Insulin Icodec benefits those needing basal insulin with weekly dosing.
All medication comparisons